DataKnowledgeCloudtrainingcoordination

L1000 LINCS DCIC PAC013 U2OS 6H I21 DMSO.tsv.gz (File)

Subject:

U2OS

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

Ncbi Taxonomy:

Homo sapiens

Taxonomy (Entity type)

File Format:

TSV

File Format (Entity type)

Disease:

osteosarcoma

Disease (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

Gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 PAC013 U2OS 6H I21 DMSO

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Anatomy:

bone tissue

Anatomy (Entity type)

Uncompressed Size In Bytes:757 KB

Size In Bytes:295 KB

Sha256:1240525256124b6452844b0986fee0065c5bd65806b59aea77b6c4928fec4444

Mime Type:application/gzip

Md5:da3d6799705a957ec395d13864e6c481

Filename:L1000_LINCS_DCIC_PAC013_U2OS_6H_I21_DMSO.tsv.gz

Creation Time:2021-01-21 00:00:00.000000

Access URL:

drs://drs.lincs-dcic.org/da3d6799705a957ec395d13864e6c481

Workbench DRS:

drs://cfde.cloud/001a775d-9893-572e-978f-49713c91177b

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 PAC013 U2OS 6H I21 DMSO Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 PAC013 U2OS 6H I21 DMSO

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.